HLB (Holding Companies) Overview

  • Year Founded
  • 1975

Year Founded

  • Status
  • Public

  • Employees
  • 157

Employees

  • Stock Symbol
  • 028300

Stock Symbol

  • Investments
  • 21

  • Share Price
  • $21.01
  • (As of Monday Closing)

HLB (Holding Companies) General Information

Description

HLB Co Ltd is engaged in the manufacture of lifeboats, special ships, safety goods, and engines. It is also engaged in pipe business and bio-technology business.

Contact Information

Formerly Known As
International Precision, Life Code International, International Stainless Valve Industry Co., Ltd., InnoGDN, Kukje Precision
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 10-5, Myeonghaksandanseo-ro
  • Yeondong-myeon
  • Sejong, 30068
  • South Korea
+82
Primary Industry
Holding Companies
Other Industries
Other Commercial Products
Stock Exchange
KRX
Corporate Office
  • 10-5, Myeonghaksandanseo-ro
  • Yeondong-myeon
  • Sejong, 30068
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HLB (Holding Companies) Stock Performance

As of 16-Nov-2026, HLB (Holding Companies)’s stock price is $21.01. Its current market cap is $2.79B with 133M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$21.01 $21.40 $16.12 - $48.24 $2.79B 133M 1.15M -$0.82

HLB (Holding Companies) Financials Summary

As of 30-Sep-2026, HLB (Holding Companies) has a trailing 12-month revenue of $69.4M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 4,305,740 4,773,396 6,537,459 5,044,771
Revenue 69,429 59,146 49,930 32,812
EBITDA (94,506) (158,338) (69,983) (152,403)
Net Income (108,603) (154,940) (67,413) (143,445)
Total Assets 656,975 645,953 602,473 579,674
Total Debt 236,606 197,877 108,631 48,625
Public Fundamental Data provided by Morningstar, Inc. disclaimer

HLB (Holding Companies) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HLB (Holding Companies)‘s full profile, request access.

Request a free trial

HLB (Holding Companies) Patents

HLB (Holding Companies) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020227591-A1 Polypeptide having antibacterial activity, composition for preventing or treating sepsis comprising same, and antibacterial composition Active 28-Feb-2019
AU-2020227591-B2 Polypeptide having antibacterial activity, composition for preventing or treating sepsis comprising same, and antibacterial composition Active 28-Feb-2019
EP-3932936-A1 Polypeptide having antibacterial activity, composition for preventing or treating sepsis comprising same, and antibacterial composition Pending 28-Feb-2019
EP-3932936-A4 Polypeptide having antibacterial activity, composition for preventing or treating sepsis comprising same, and antibacterial composition Pending 28-Feb-2019
US-12371453-B2 Polypeptide having antibacterial activity, composition for preventing or treating sepsis comprising same, and antibacterial composition Active 28-Feb-2019 C07K7/06
To view HLB (Holding Companies)’s complete patent history, request access »

HLB (Holding Companies) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HLB (Holding Companies) Investments & Acquisitions (21)

HLB (Holding Companies)’s most recent deal was a PIPE with HLB Pep for . The deal was made on 10-Mar-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HLB Pep 10-Mar-2025 PIPE Drug Discovery
HLB Pep 10-Mar-2025 Merger/Acquisition Drug Discovery
HLB Genex 12-Dec-2024 PIPE Drug Discovery
HLB Therapeutics 01-Apr-2024 PIPE Drug Discovery
Jiangsu Hengrui Pharmaceuticals (Global rights of Camrelizumab) 06-Mar-2024 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

HLB (Holding Companies) ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

22.25 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Supplies

Subindustry

of 60

Rank

Percentile

To view HLB (Holding Companies)’s complete esg history, request access »

HLB (Holding Companies) Exits (1)

HLB (Holding Companies)’s most recent exit was on 27-Apr-2021 from Verismo Therapeutics. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Verismo Therapeutics 27-Apr-2021 Completed
  • 2 buyers
To view HLB (Holding Companies)’s complete exits history, request access »

HLB (Holding Companies) Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
HLB Investment Seoul, South Korea 2021
HLB bioStep Company Incheon, South Korea 2012
Elevar Therapeutics Fort Lee, NJ 2005
HLB Pep Jeonnam-Gwangju, South Korea 2000
Corki Seoul, South Korea

HLB (Holding Companies) FAQs

  • When was HLB (Holding Companies) founded?

    HLB (Holding Companies) was founded in 1975.

  • Where is HLB (Holding Companies) headquartered?

    HLB (Holding Companies) is headquartered in Sejong, South Korea.

  • What is the size of HLB (Holding Companies)?

    HLB (Holding Companies) has 157 total employees.

  • What industry is HLB (Holding Companies) in?

    HLB (Holding Companies)’s primary industry is Holding Companies.

  • Is HLB (Holding Companies) a private or public company?

    HLB (Holding Companies) is a Public company.

  • What is HLB (Holding Companies)’s stock symbol?

    The ticker symbol for HLB (Holding Companies) is 028300.

  • What is the current stock price of HLB (Holding Companies)?

    As of 16-Nov-2026 the stock price of HLB (Holding Companies) is $21.01.

  • What is the current market cap of HLB (Holding Companies)?

    The current market capitalization of HLB (Holding Companies) is $2.79B.

  • What is HLB (Holding Companies)’s current revenue?

    The trailing twelve month revenue for HLB (Holding Companies) is $69.4M.

  • What is HLB (Holding Companies)’s annual earnings per share (EPS)?

    HLB (Holding Companies)’s EPS for 12 months was -$0.82.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process